0001140361-22-041405.txt : 20221114 0001140361-22-041405.hdr.sgml : 20221114 20221114163628 ACCESSION NUMBER: 0001140361-22-041405 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221114 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Forian Inc. CENTRAL INDEX KEY: 0001829280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 853467693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40146 FILM NUMBER: 221386606 BUSINESS ADDRESS: STREET 1: 41 UNIVERSITY DRIVE STREET 2: SUITE 400 CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-757-8707 MAIL ADDRESS: STREET 1: 41 UNIVERSITY DRIVE STREET 2: SUITE 400 CITY: NEWTOWN STATE: PA ZIP: 18940 8-K 1 brhc10044015_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  November 14, 2022

FORIAN INC.
(Exact Name of Registrant as Specified in Charter)

Delaware
001-40146
85-3467693
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

41 University Drive, Suite 400, Newtown, PA
   18940
(Address of principal executive offices)
  
(Zip Code)

Registrant’s telephone number, including area code:  (267) 225-6263

 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value
FORA
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).          ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          ☐

Item 2.02
Results of Operations and Financial Condition

On November 14, 2022, Forian Inc. issued a press release announcing its financial results for the quarter ended September 30, 2022. A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01
Financial Statements and Exhibits

(d)
Exhibits.

The Company hereby files or furnishes, as applicable, the following exhibits:

Exhibit No.
  
Description
     
 
Press Release, dated November 14, 2022 (furnished herewith)
     
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)

2
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
FORIAN INC.
     
 Dated: November 14, 2022
By:
/s/ Edward Spaniel, Jr.
 
Name:
Edward Spaniel, Jr.
 
Title:
Executive Vice President, General Counsel and Secretary


3
 EX-99.1 2 brhc10044015_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

Forian Inc.
Announces Third Quarter 2022 Financial Results
Revenue grows to $7.2 million
On track to exceed 2022 revenue guidance
Newtown, PA / November 14, 2022 / Forian Inc. (Nasdaq: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the quarter ended September 30, 2022.
“Forian’s third quarter results demonstrate our business model’s ability to generate significant organic growth at a convincing pace,” said Max Wygod, Forian Executive Chairman. “The strong results enable us to report that we are on track to exceed the high-end of our revenue range for full year 2022.”
Forian Chief Executive Officer Dan Barton continued, “Third quarter 2022 financial results continue to demonstrate significant revenue growth, especially in our healthcare information offerings.  This strong revenue growth coupled with the consistency in our cannabis business and the success of our cost management efforts provide the blueprint to reduce Net Loss and become Adjusted EBITDA positive in the second half of 2023.”
Third Quarter 2022 Financial Results

●
Forian delivered the following results for the third quarter of 2022:

   
Three Months Ended
          
Year-over-
Year %
Change
     
   
September 30,
   
2022
    
2021
   
Unaudited
    
Unaudited
Total revenues
  
$
7,176,328
    
$
4,961,755
    
45%

Net loss
  
$
(5,127,624
)
  
$
(7,021,722
)
  
27%

Basic and diluted net loss per common share
  
$
(0.16
)
  
$
(0.22
)
  
29%

                       
Adjusted EBITDA1
  
$
(2,145,180
)
  
$
(4,122,830
)
  
48%



●
Revenue for the quarter was $7.2 million, an increase of $2.2 million versus the prior year and 10% sequentially over the second quarter of 2022.

●
Net Loss for the quarter was $5.1 million, or $0.16 per share, compared to $7.0 million, or $0.22 per share, in the prior year.

●
Adjusted EBITDA1 for the quarter was negative $2.2 million, compared to negative $4.1 million in the prior year.

●
Cash, cash equivalents and marketable securities at the end of the quarter was $20.6 million.

1This release uses non-GAAP financial measures that are adjusted for the impact of various U.S. GAAP items. See the section titled “Non-GAAP Financial Measures” and the table entitled “Reconciliation of U.S. GAAP to Non-GAAP Financial Measures” below for details.
Third Quarter 2022 Operational Highlights

●
Year-to-date healthcare information new customer wins on par with total new wins in 2021

●
Cross selling and upselling initiatives increased revenue from existing clients

●
Strong cannabis software sales continued through the third quarter

●
Successful implementation of cost management strategies

Quarterly Conference Call and Webcast
Forian will host a conference call and webcast at 4:30 p.m. ET on November 14, 2022 to discuss its financial results with the investment community.  To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/8vfqfw2e. This information is also available on our website at www.forian.com/investors. To be included on the Company’s email distribution list, please sign up at www.forian.com/investors.
About Forian
Forian provides a unique suite of SaaS solutions, data management capabilities and proprietary data and analytics to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators and regulators. For more information, please visit the Company’s website at www.forian.com.
Media and Investor Contact:
267-225-6263
forian.com/investors
ir@forian.com
Source: Forian Inc.
Cautionary Statements Regarding Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions and variations or negatives of these words. In particular, this release includes an estimate of our full year 2022 revenue outlook as of November 14, 2022. Estimating financial performance accurately for future periods is difficult as it involves assumptions and internal estimates that may prove to be incorrect and is based on plans and circumstances that may change. There is therefore a significant risk that actual results could differ materially from the outlook we have provided in this release, and we have no obligation to update such outlook except as may be required under applicable law. Forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the control of Forian, and are not guarantees of future results, such as statements about the anticipated benefits of the business combination transaction involving Forian, Medical Outcomes Research Analytics, LLC and Helix Technologies, Inc. (“Helix”), future financial and operating results, company strategy and intended product offerings and market positioning. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with: the impact of the COVID-19 pandemic on Forian’s business, operations, strategy and goals; Forian’s ability to execute on its strategy; the timing of the introduction of new product offerings; and the additional risks and uncertainties set forth more fully under the caption “Risk Factors” in Forian’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 31, 2022, and elsewhere in Forian’s filings and reports with the SEC. Forward-looking statements contained in this announcement are made as of the date hereof, and Forian undertakes no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.
FORIAN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
   
September 30,
2022
    
December 31,
2021
  
         
   
(UNAUDITED)
        
ASSETS
            
Current assets:
            
Cash and cash equivalents
  
$
1,585,594
    
$
18,663,805
  
Marketable securities
    
19,046,961
      
12,399,361
  
Accounts receivable, net
    
3,553,323
      
1,947,540
  
Contract assets
    
1,978,181
      
1,056,891
  
Prepaid expenses
    
1,205,630
      
1,017,927
  
Other assets
    
436,101
      
900,242
  
Total current assets
    
27,805,790
      
35,985,766
  
 
                
Property and equipment, net
    
2,870,667
      
1,531,959
  
Intangible assets, net
    
7,344,677
      
9,051,184
  
Goodwill
    
9,099,372
      
9,099,372
  
Right of use assets, net
    
706,272
      
859,637
  
Deposits and other assets
    
274,532
      
314,443
  
Total assets
  
$
48,101,310
    
$
56,842,361
  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
                
Current liabilities:
                
Accounts payable
  
$
896,916
    
$
1,125,067
  
Accrued expenses
    
4,557,385
      
4,068,109
  
Short-term operating lease liabilities
    
265,474
      
247,325
  
Notes payable
    
-
      
13,122
  
Warrant liability
    
26,079
      
369,234
  
Deferred revenues
    
2,685,027
      
976,268
  
Total current liabilities
    
8,430,881
      
6,799,125
  
 
                
Long-term liabilities:
                
Long-term operating lease liabilities
    
444,996
      
611,523
  
Convertible notes payable, net of debt issuance costs ($6,000,000 in principal is held by a related party)
    
24,893,488
      
24,260,448
  
Total long-term liabilities
    
25,338,484
      
24,871,971
  
                 
Total liabilities
    
33,769,365
      
31,671,096
  
                 
Commitments and contingencies
                
Stockholders’ equity:
                
Preferred Stock; par value $0.001; 5,000,000 Shares authorized; 0 issued and outstanding as of September 30, 2022 and December 31, 2021
    
-
      
-
  
Common Stock; par value $0.001; 95,000,000 Shares authorized; 32,138,000 issued and outstanding as of September 30, 2022 and 31,773,154 issued and outstanding as of December 31, 2021
    
32,138
      
31,773
  
Additional paid-in capital
    
69,535,194
      
57,959,622
  
Accumulated deficit
    
(55,235,387
)
    
(32,820,130
)
Total stockholders’ equity
    
14,331,945
      
25,171,265
  
Total liabilities and stockholders’ equity
  
$
48,101,310
    
$
56,842,361
  

FORIAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
   
For the Three Months Ended September 30,
    
For the Nine Months Ended September 30,
  
   
2022
    
2021
    
2022
    
2021
  
                         
Revenues:
                        
Information and Software
  
$
6,780,680
    
$
4,489,177
    
$
18,674,213
    
$
9,661,826
  
Services
    
341,173
      
269,753
      
1,168,034
      
858,400
  
Other
    
54,475
      
202,825
      
259,618
      
610,123
  
Total revenues
    
7,176,328
      
4,961,755
      
20,101,865
      
11,130,349
  
                                 
Costs and Expenses:
                                
Cost of revenues
    
1,839,996
      
1,337,981
      
5,154,353
      
3,028,657
  
Research and development
    
3,259,511
      
2,612,184
      
9,869,435
      
6,059,948
  
Sales and marketing
    
1,525,286
      
1,088,203
      
4,455,269
      
2,864,213
  
General and administrative
    
4,659,959
      
6,673,723
      
15,618,570
      
16,035,981
  
Separation expenses
    
-
      
-
      
5,611,857
      
-
  
Gain on sale of assets
    
-
      
-
      
(202,159
)
    
-
  
Depreciation and amortization
    
842,933
      
598,565
      
2,052,729
      
1,381,637
  
Transaction related expenses
    
-
      
-
      
-
      
1,210,279
  
Total costs and expenses
    
12,127,685
      
12,310,656
      
42,560,054
      
30,580,715
  
                                 
Loss From Operations
    
(4,951,357
)
    
(7,348,901
)
    
(22,458,189
)
    
(19,450,366
)
                                 
Other Income (Expense):
                                
Change in fair value of warrant liability
    
8,539
      
251,778
      
343,155
      
746,605
  
Interest and investment income
    
89,160
      
1,903
      
112,602
      
4,601
  
Interest expense
    
(198,738
)
    
(79,422
)
    
(659,425
)
    
(101,325
)
Foreign currency related (losses) gains
    
(65,228
)
    
152,920
      
266,600
      
298,170
  
Total other income (expense), net
    
(166,267
)
    
327,179
      
62,932
      
948,051
  
                                 
Net loss before income taxes
    
(5,117,624
)
    
(7,021,722
)
    
(22,395,257
)
    
(18,502,315
)
Income tax expense
    
(10,000
)
    
-
      
(20,000
)
    
-
  
                                 
Net Loss
    
(5,127,624
)
    
(7,021,722
)
    
(22,415,257
)
    
(18,502,315
)
                                 
Basic and diluted net loss per common share
  
$
(0.16
)
  
$
(0.22
)
  
$
(0.70
)
  
$
(0.64
)
Weighted-average shares outstanding
    
32,088,358
      
31,332,735
      
31,978,719
      
28,814,825
  

FORIAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
             
   
For the Nine Months Ended September 30,
  
   
2022
    
2021
  
CASH FLOWS FROM OPERATING ACTIVITIES:
            
Net loss
  
$
(22,415,257
)
  
$
(18,502,315
)
Adjustments to reconcile net loss to net cash used in operating activities:
                
Depreciation and amortization
    
2,052,729
      
1,381,637
  
Amortization on right of use asset
    
153,365
      
166,489
  
Gain on sale of assets
    
(202,159
)
    
-
  
Amortization of debt issuance costs
    
3,999
      
444
  
Accrued interest on Convertible Notes
    
629,041
      
70,000
  
Realized and unrealized gain on marketable securities
    
(110,914
)
    
(3,295
)
Provision for doubtful accounts
    
142,846
      
89,130
  
Stock-based compensation expense
    
11,634,022
      
6,245,679
  
Change in fair value of warrant liability
    
(343,155
)
    
(746,605
)
Foreign currency related (gains) losses
    
14,803
      
(15,030
)
Issuance of warrants in connection with transaction expenses
    
-
      
389,976
  
Change in operating assets and liabilities:
                
Accounts receivable
    
(1,761,038
)
    
(1,757,660
)
Contract assets
    
(921,290
)
    
(147,651
)
Prepaid expenses
    
(187,703
)
    
(576,836
)
Changes in lease liabilities during the period
    
(148,378
)
    
(186,383
)
Deposits and other assets
    
504,052
      
(120,732
)
Accounts payable
    
(228,151
)
    
(234,152
)
Accrued expenses
    
481,159
      
559,770
  
Deferred revenues
    
1,708,759
      
202,337
  
Net cash used in operating activities
    
(8,993,270
)
    
(13,185,197
)
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
                
Additions to property and equipment
    
(1,695,937
)
    
(640,080
)
Proceeds from sale of assets
    
225,575
      
-
  
Purchase of marketable securities
    
(42,929,102
)
    
(24,903,107
)
Sale of marketable securities
    
36,392,416
      
24,009,003
  
Cash acquired as part of business combination
    
-
      
1,310,977
  
Net cash used in investing activities
    
(8,007,048
)
    
(223,207
)
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
                
Proceeds from exercise of MOR Class B options
    
-
      
292,830
  
Payments on notes payable and financing arrangements
    
(13,122
)
    
(5,551
)
Payment of employee withholding tax related to restricted stock units
    
(58,085
)
    
-
  
Proceeds from exercise of common stock options
    
-
      
48,570
  
Proceeds from sale of common stock
    
-
      
11,968,652
  
Proceeds from issuance of convertible notes
    
-
      
23,978,670
  
Net cash (used in) provided by financing activities
    
(71,207
)
    
36,283,171
  
                 
Effect of foreign exchange rate changes on cash
    
(6,686
)
    
(5,132
)
                 
Net change in cash
    
(17,078,211
)
    
22,869,635
  
                 
Cash and cash equivalents, beginning of period
    
18,663,805
      
665,463
  
                 
Cash and cash equivalents, end of period
  
$
1,585,594
    
$
23,535,098
  
                 
Supplemental disclosure of cash flow information
                
Cash paid for interest
  
$
-
    
$
724
  
Cash paid for taxes
  
$
2,550
    
$
-
  
Non-cash Investing Activities:
                
Non-cash consideration for Helix acquisition
  
$
-
    
$
18,454,784
  

Non-GAAP Financial Measures
In this press release, we have provided certain non-GAAP measures, which we define as financial information that has not been prepared in accordance with U.S. GAAP. The non-GAAP financial measure provided herein is earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”), which should be viewed as supplemental to, and not as an alternative for, net income or loss calculated in accordance with U.S. GAAP (referred to below as “net loss”).
Adjusted EBITDA is used by our management as an additional measure of our Company’s performance for purposes of business decision-making, including developing budgets, managing expenditures and evaluating potential acquisitions or divestitures. Period-to-period comparisons of Adjusted EBITDA help our management identify additional trends in our Company’s financial results that may not be shown solely by period-to-period comparisons of net income. In addition, we may use Adjusted EBITDA in the incentive compensation programs applicable to some of our employees in order to evaluate our Company’s performance. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, particularly those items that are recurring in nature. In order to compensate for those limitations, management also reviews the specific items that are excluded from Adjusted EBITDA, but included in net income, as well as trends in those items.
We believe that the presentation of Adjusted EBITDA is useful to investors in their analysis of our results for reasons similar to the reasons why our management finds it useful and because it helps facilitate investor understanding of decisions made by management in light of the performance metrics used in making those decisions. In addition, as more fully described below, we believe that providing Adjusted EBITDA, together with a reconciliation of net loss to Adjusted EBITDA, helps investors make comparisons between our Company and other companies that may have different capital structures, different effective income tax rates and tax attributes, different capitalized asset values and/or different forms of employee compensation. However, Adjusted EBITDA is not intended as a substitute for comparisons based on net loss. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measures and the corresponding U.S. GAAP measures provided by each company under applicable SEC rules.
The following is an explanation of the items excluded by us from Adjusted EBITDA but included in net loss:

•
Depreciation and Amortization. Depreciation and amortization expense is a non-cash expense relating to capital expenditures and intangible assets arising from acquisitions that are expensed on a straight-line basis over the estimated useful life of the related assets. We exclude depreciation and amortization expense from Adjusted EBITDA because we believe that (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired tangible and intangible assets. Accordingly, we believe that this exclusion assists management and investors in making period-to-period comparisons of operating performance. Investors should note that the use of tangible and intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation and should also note that such expense will recur in future periods.


•
Stock-Based Compensation Expense. Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards to employees. We believe that excluding the effect of stock-based compensation from Adjusted EBITDA assists management and investors in making period-to-period comparisons in our Company’s operating performance because (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of the timing of grants of new stock-based awards, including grants in connection with acquisitions. Additionally, we believe that excluding stock-based compensation from Adjusted EBITDA assists management and investors in making meaningful comparisons between our Company’s operating performance and the operating performance of other companies that may use different forms of employee compensation or different valuation methodologies for their stock-based compensation. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods. Investors should also note that such expenses will recur in the future.


•
Interest Expense. Interest expense is associated with the 3.5% Convertible Notes due 2025 entered into on September 1, 2021, in the amount of $24,000,000. The Notes are due on September 1, 2025, and accrue interest at an annual rate of 3.5%. We exclude interest expense from Adjusted EBITDA (i) because it is not directly attributable to the performance of our business operations and, accordingly, its exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different capital structures. Investors should note that interest expense associated with the Notes will recur in future periods.


•
Investment Income. Investment income is associated with the level of marketable debt securities and other interest-bearing accounts in which we invest. Interest and investment income can vary over time due to a variety of financing transactions, changes in interest rates, cash used to fund operations and capital expenditures and acquisitions that we have entered into or may enter into in the future. We exclude interest and investment income from Adjusted EBITDA (i) because these items are not directly attributable to the performance of our business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different capital structures. Investors should note that interest income will recur in future periods.


•
Foreign Currency Related Gains (Losses). Foreign currency related gains (losses) result from foreign currency transactions and translation gains (losses) related to Engeni S.A., a former subsidiary of our Company acquired as part of the acquisition of Helix. We exclude foreign currency related gains (losses) from Adjusted EBITDA (i) because these items are not directly attributable to the performance of our business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different capital structures. Investors should note that foreign currency related gains (losses) may recur in future periods.


•
Other Items. We engage in other activities and transactions that can impact our net loss. In the periods being reported, these other items included: (i) change in fair value of warrant liability which related to warrants assumed in the acquisition of Helix; (ii) transaction related expenses which consist of professional fees and other expenses incurred in connection with the acquisition of Helix; and (iii) other income which consists of profits on marketable security investments. We exclude these other items from Adjusted EBITDA because we believe these activities or transactions are not directly attributable to the performance of our business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance. Investors should note that some of these other items may recur in future periods.


•
Gain on sale of assets. On March 3, 2022, we sold certain assets consisting of customer contracts, accounts receivable and other property related to our security monitoring services for $225,575 resulting in a gain of $202,159, which is included in operating expenses in the condensed consolidated statements of operations.


•
Separation expenses. During March 2022, we transferred certain development activities from our former Engeni S.A. subsidiary to outsourced development facilities. As a result, we incurred $194,814 in severance and related costs to be recorded as a charge to operating expenses in 2022. Additionally, on March 2, 2022, we and the former chief executive officer and the former chief financial officer of Helix mutually agreed not to renew special advisor agreements. Per the terms of the agreements, options to purchase 366,166 shares of our common stock will continue to vest according to their original terms through March 2, 2023, and unvested stock options to purchase 732,332 shares of our common stock were forfeited. The advisors are not required to perform services to our Company beyond the non-renewal date of March 2, 2022. As a result, we recorded $5,417,043 of stock compensation expenses related to the options that will vest over the twelve months ending March 2, 2023 during March 2022. We exclude these other items from Adjusted EBITDA because we believe these costs are not directly attributable to the performance of our business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance. Investors should note that separation expenses are non-recurring.


•
Income tax expense. Medical Outcomes Research Analytics, LLC was organized as a limited liability company until the completion of the Helix acquisition. As a result, we were treated as a partnership for federal and state income tax purposes through March 2, 2021, and our taxable income and losses are reported by our members on their individual tax returns for such period. Therefore, we did not record any income tax expense or benefit through March 2, 2021. We incurred a net loss for financial reporting and income tax reporting purposes for this year. Accordingly, any benefit for federal and state income taxes benefit has been entirely offset by a valuation allowance against the related deferred tax net assets. We exclude the income tax expense from Adjusted EBITDA (i) because we believe that the income tax expense is not directly attributable to the underlying performance of our business operations and, accordingly, its exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different tax attributes.

There are limitations to using non-GAAP financial measures because non-GAAP financial measures are not prepared in accordance with U.S. GAAP and may be different from non-GAAP financial measures provided by other companies.
The non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact upon our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which items are adjusted to calculate our non-GAAP financial measures. We compensate for these limitations by analyzing current and future results on a U.S. GAAP basis as well as a non-GAAP basis and also by providing U.S. GAAP measures in our public disclosures.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with U.S. GAAP. We encourage investors and others to review our financial information in its entirety, not to rely on any single financial measure to evaluate our business and to view our non-GAAP financial measures in conjunction with the most directly comparable U.S. GAAP financial measures.
The following table reconciles the specific items excluded from U.S. GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:
FORIAN INC.
Reconciliation of US GAAP to Non-GAAP Financial Measures
(UNAUDITED)
   
For the Three Months Ended September 30,
    
For the Nine Months Ended September 30,
  
   
2022
    
2021
    
2022
    
2021
  
Revenues:
                        
Information and Software
  
$
6,780,680
    
$
4,489,177
    
$
18,674,213
    
$
9,661,826
  
Services
    
341,173
      
269,753
      
1,168,034
      
858,400
  
Other
    
54,475
      
202,825
      
259,618
      
610,123
  
Total revenues
  
$
7,176,328
    
$
4,961,755
    
$
20,101,865
    
$
11,130,349
  
                                 
Net loss
  
$
(5,127,624
)
  
$
(7,021,722
)
  
$
(22,415,257
)
  
$
(18,502,315
)
                                 
Depreciation and amortization
    
842,933
      
598,565
      
2,052,729
      
1,381,637
  
Stock based compensation expense
    
1,963,244
      
2,627,506
      
11,634,022
      
6,245,679
  
Change in fair value of warrant liability
    
(8,539
)
    
(251,778
)
    
(343,155
)
    
(746,605
)
Transaction related expenses
    
-
      
-
      
-
      
1,210,279
  
Interest and investment income (expense)
    
109,578
      
77,519
      
546,823
      
96,724
  
Foreign currency related (gains) losses
    
65,228
      
(152,920
)
    
(266,600
)
    
(298,170
)
Gain on sale of security monitoring assets
    
-
      
-
      
(202,159
)
    
-
  
Severance expense
    
-
      
-
      
194,814
      
-
  
Income tax expense
    
10,000
      
-
      
20,000
      
-
  
                                 
Adjusted EBITDA
  
$
(2,145,180
)
  
$
(4,122,830
)
  
$
(8,778,783
)
  
$
(10,612,771
)


EX-101.SCH 3 fora-20221114.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 fora-20221114_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 fora-20221114_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 logo.jpg begin 644 logo.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information
Nov. 14, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 14, 2022
Entity File Number 001-40146
Entity Registrant Name FORIAN INC.
Entity Central Index Key 0001829280
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-3467693
Entity Address, Address Line One 41 University Drive
Entity Address, Address Line Two Suite 400
Entity Address, City or Town Newtown
Entity Address, State or Province PA
Entity Address, Postal Zip Code 18940
City Area Code 267
Local Phone Number 225-6263
Title of 12(b) Security Common Stock, $0.001 par value
Trading Symbol FORA
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 8 brhc10044015_8k_htm.xml IDEA: XBRL DOCUMENT 0001829280 2022-11-14 2022-11-14 false 0001829280 8-K 2022-11-14 FORIAN INC. DE 001-40146 85-3467693 41 University Drive Suite 400 Newtown PA 18940 267 225-6263 false false false false Common Stock, $0.001 par value FORA NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 24 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://moranalytics.co/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc10044015_8k.htm brhc10044015_ex99-1.htm fora-20221114.xsd fora-20221114_lab.xml fora-20221114_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10044015_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "brhc10044015_8k.htm" ] }, "labelLink": { "local": [ "fora-20221114_lab.xml" ] }, "presentationLink": { "local": [ "fora-20221114_pre.xml" ] }, "schema": { "local": [ "fora-20221114.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "fora", "nsuri": "http://moranalytics.co/20221114", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10044015_8k.htm", "contextRef": "c20221114to20221114", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://moranalytics.co/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10044015_8k.htm", "contextRef": "c20221114to20221114", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://moranalytics.co/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 15 0001140361-22-041405-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-041405-xbrl.zip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